Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder

BACKGROUND: We evaluated the effects of once-daily extended-release quetiapine fumarate (quetiapine XR) on patient-reported outcomes in generalized anxiety disorder (GAD). METHODS: This is a report of a pooled analysis from three acute 8-week, randomized, placebocontrolled, fixed-dose (50, 150, 300...

Descripción completa

Detalles Bibliográficos
Autores principales: Endicott, Jean, Svedsäter, Henrik, Locklear, Julie C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404593/
https://www.ncbi.nlm.nih.gov/pubmed/22848184
http://dx.doi.org/10.2147/NDT.S32320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404593/
https://www.ncbi.nlm.nih.gov/pubmed/22848184
http://dx.doi.org/10.2147/NDT.S32320

Ejemplares similares